Commentary on 'a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS'
Amyotroph Lateral Scler
.
2008 Aug;9(4):254-6.
doi: 10.1080/17482960802192324.
Authors
Jeremy M Shefner
1
,
P Nigel Leigh
Affiliation
1
Department of Neurology, SUNY Upstate Medical University, Syracuse, New York 13210, USA. shefnerj@upstate.edu
PMID:
18642137
DOI:
10.1080/17482960802192324
No abstract available
Publication types
Comment
MeSH terms
Amyotrophic Lateral Sclerosis / drug therapy*
Drug Therapy, Combination
Humans
Neuroprotective Agents / administration & dosage
Neuroprotective Agents / therapeutic use*
Randomized Controlled Trials as Topic*
Substances
Neuroprotective Agents